CDH2 and ovarian cancer: Consistent with the changes in the expression and localisation of N-cadherin, vimentin and β-catenin, EGF also induced a motile phenotype in ovarian cancer cells as evaluated by wound-healing assay in serum-free medium (Ahmed et al, 2006; Lim et al, 2007).